ADC Therapeutics (ADCT) News Today → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free ADCT Stock Alerts $4.34 -0.10 (-2.25%) (As of 04:10 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineADC Therapeutics SA (NYSE:ADCT) Receives Average Rating of "Hold" from Brokeragesamericanbankingnews.com - April 22 at 4:12 AMGenerex Biotechnology (OTCMKTS:GNBT) versus ADC Therapeutics (NYSE:ADCT) Head-To-Head Contrastamericanbankingnews.com - April 21 at 1:10 AMAnalysts Set Expectations for ADC Therapeutics SA's Q1 2024 Earnings (NYSE:ADCT)americanbankingnews.com - April 19 at 1:48 AMADC Therapeutics SA (NYSE:ADCT) Short Interest Up 5.7% in Marchamericanbankingnews.com - April 18 at 7:20 AMHC Wainwright Comments on ADC Therapeutics SA's Q1 2024 Earnings (NYSE:ADCT)marketbeat.com - April 18 at 5:59 AMShort Interest in ADC Therapeutics SA (NYSE:ADCT) Rises By 5.7%marketbeat.com - April 16 at 6:52 PMBuy Rating Affirmed for ADC Therapeutics on Strong Preclinical Data and Promising Trial Progressmarkets.businessinsider.com - April 16 at 11:05 AMADC Therapeutics' (ADCT) "Buy" Rating Reaffirmed at HC Wainwrightamericanbankingnews.com - April 16 at 4:46 AMHC Wainwright Reiterates "Buy" Rating for ADC Therapeutics (NYSE:ADCT)marketbeat.com - April 15 at 8:29 AMADC Therapeutics' (ADCT) "Buy" Rating Reiterated at Guggenheimmarketbeat.com - April 5 at 10:26 AMADC Therapeutics gains after data for lymphoma therapymsn.com - April 4 at 7:48 PMADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphomaglobenewswire.com - April 4 at 7:00 AMADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024globenewswire.com - April 3 at 7:00 AMADC Therapeutics Makes Grants to New Employees Under Inducement Planfinance.yahoo.com - April 1 at 8:10 PMADC Therapeutics SA (NYSE:ADCT) Receives Consensus Rating of "Hold" from Brokeragesmarketbeat.com - March 28 at 8:32 AMADC Therapeutics (NYSE:ADCT) Earns Buy Rating from Analysts at Guggenheimmarketbeat.com - March 28 at 8:28 AMADC Therapeutics (NYSE:ADCT) Earns "Outperform" Rating from Royal Bank of Canadamarketbeat.com - March 18 at 3:46 PMUS$10.00 - That's What Analysts Think ADC Therapeutics SA (NYSE:ADCT) Is Worth After These Resultsfinance.yahoo.com - March 16 at 1:49 PMADC Therapeutics SA (ADCT) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 15 at 8:31 PMQ4 2023 ADC Therapeutics SA Earnings Callfinance.yahoo.com - March 14 at 10:46 AMADC Therapeutics SA (ADCT) Reports Mixed 2023 Financial Results Amid Strategic Resetfinance.yahoo.com - March 13 at 1:21 PMmarketbeat.com - March 13 at 9:52 AMmarketbeat.com - March 13 at 9:48 AMmarketbeat.com - March 13 at 9:38 AMmarketbeat.com - March 13 at 9:34 AMADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updatesglobenewswire.com - March 13 at 7:00 AMADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summitglobenewswire.com - March 6 at 7:15 AMADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March 13, 2024globenewswire.com - March 6 at 7:00 AMADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual Meetingglobenewswire.com - March 5 at 5:45 PMADC Therapeutics SA: ADC Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conferencefinanznachrichten.de - February 27 at 10:07 AMADC Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conferenceglobenewswire.com - February 27 at 7:00 AMADC Therapeutics (ADCT) Scheduled to Post Earnings on Mondaymarketbeat.com - February 25 at 7:32 AMADC Therapeutics (ADCT) Price Target Increased by 9.38% to 8.93msn.com - February 24 at 9:37 AMADC Therapeutics Stock (NYSE:ADCT), Quotes and News Summarybenzinga.com - February 23 at 9:19 AMEarnings Preview: Cytek Biosciences, Inc. (CTKB) Q4 Earnings Expected to Declinefinance.yahoo.com - February 21 at 3:39 PMEarnings Preview: ADC Therapeutics SA (ADCT) Q4 Earnings Expected to Declinefinance.yahoo.com - February 20 at 1:52 PMThe 3 Biotech Stocks That Could Make Your February Unforgettablemsn.com - February 15 at 12:25 PMThe 3 Biotech Stocks That Could Make Your February Unforgettableinvestorplace.com - February 15 at 11:57 AMThe 3 Most Undervalued Biotech Stocks to Buy in February 2024msn.com - February 8 at 2:02 PMAdc Therapeutics SA (ADCT)uk.investing.com - January 31 at 1:37 AMADC Therapeutics SA (NYSE:ADCT) Sees Significant Drop in Short Interestmarketbeat.com - January 30 at 3:47 AMIs ADC Therapeutics (ADCT) Outperforming Other Medical Stocks This Year?finance.yahoo.com - January 19 at 2:31 PMADC Therapeutics (ADCT) Rises 43% in a Month: Here's Whyfinance.yahoo.com - January 19 at 2:31 PMADC Therapeutics SA (NYSE:ADCT) Given Consensus Rating of "Hold" by Brokeragesmarketbeat.com - January 10 at 4:14 AMRBC Capital Keeps Their Buy Rating on ADC Therapeutics (ADCT)markets.businessinsider.com - January 6 at 11:13 AMOptimistic Outlook: Buy Rating for ADC Therapeutics Amid Anticipated Clinical Milestones and Strong Financialsmarkets.businessinsider.com - January 5 at 10:32 PMADC Therapeutics SA: ADC Therapeutics Regains Compliance with NYSE Continued Listing Standardsfinanznachrichten.de - January 4 at 12:48 PMADC Therapeutics SA: ADC Therapeutics Provides Business Updatesfinanznachrichten.de - January 4 at 7:34 AMADC Therapeutics Provides Business Updatesfinance.yahoo.com - January 4 at 7:33 AMADC Therapeutics Regains Compliance with NYSE Continued Listing Standardsfinance.yahoo.com - January 4 at 7:33 AM Get ADC Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADCT and its competitors with MarketBeat's FREE daily newsletter. Email Address The Next Step of Their Control Is Here … (Ad)Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you. 4 simple steps to protect your privacy and money before it’s too late. ADCT Media Mentions By Week ADCT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADCT News Sentiment▼0.000.33▲Average Medical News Sentiment ADCT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADCT Articles This Week▼42▲ADCT Articles Average Week Get ADC Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADCT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ANRO News ESPR News AMRN News FBLG News ATAI News NATR News ORGO News RANI News NKTX News ANL News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ADCT) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsTrump is sounding the alarmPreserve Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ADC Therapeutics SA Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
